Exosome Diagnostic and Therapeutic Market Demand, Size and Growth Rate Forecast 2035
According to market projection, the market will grow from USD 196.02 million in 2026 to USD 40,931.13 million by 2035 at a remarkable 81.03% CAGR, with exosome diagnostics, kits and reagents, stem cell-derived exosomes, and cancer applications leading demand. The analysis also identifies North America as the current market leader, Asia Pacific as the fastest-growing region, and highlights the competitive strategies of companies including Thermo Fisher Scientific, QIAGEN, Bio-Techne, Exosome Diagnostics, Capricor Therapeutics, and Evox Therapeutics.
Last Updated : 21 July 2026
Category: Diagnostics
Insight Code: 5354
Format: PDF / PPT / Excel